Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.
about
Thymectomy for non-thymomatous myasthenia gravisThymectomy for non-thymomatous myasthenia gravisThe MG Composite: A valid and reliable outcome measure for myasthenia gravis.Psychometric evaluation of the myasthenia gravis composite using Rasch analysis.The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.A conceptual framework for evaluating impairments in myasthenia gravis.Repeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development.Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale.Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study.Recommendations for myasthenia gravis clinical trials.Intravenous immunoglobulin as treatment for myasthenia gravis: current evidence and outcomes.Physician- and self-assessed myasthenia gravis activities of daily living score.Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis.Development and validation of the Myasthenia Gravis Impairment Index.Patient registries: useful tools for clinical research in myasthenia gravis.The best of both worlds: Using patient-reported plus physician-scored measures during the evaluation of myasthenia gravis.Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validation.Brazilian-Portuguese translation, cross-cultural adaptation and validation of the Myasthenia Gravis Composite scale. A multicentric study.Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients.Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version.Validation of the Besta Neurological Institute rating scale for myasthenia gravis.Diurnal and day-to-day variation of isometric muscle strength in myasthenia gravis.The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.Health-related quality-of-life and treatment targets in myasthenia gravis.Translation and validation of the arabic version of the revised 15-item myasthenia gravis quality-of-life questionnaire.The MG-QOL15 Japanese version: validation and associations with clinical factors.Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Identification of international classification of functioning, disability and health relevant categories to describe functioning and disability of patients with myasthenia gravis.What is the role of adipokines in myasthenia gravis?
P2860
Q24197482-FBB12F86-72CE-438A-B7C5-E978A9D7E64BQ24240863-E151CEA9-B4E4-4202-BB15-77F33F481550Q30424639-F5454538-4C3E-461D-BEB0-4C857A8B1C98Q30455482-31ECAF51-2AE5-4332-A119-C71C3F043BE3Q30456336-B64DAA83-4B97-4761-A18F-C6C51BC44EB7Q33638581-854D6BBE-B815-4189-B20D-7F2122913A6FQ34612356-30D559CB-5813-4B00-BD80-2A52B938D2ADQ35884892-F42CC169-0C51-4CDA-BA12-4F5FC5973439Q37589680-A0974158-9CD2-4691-BC7E-FCAB184C5C48Q37681359-30B39C32-30ED-4644-AF1F-E186C2B99C92Q38009753-2A72E4D0-586D-4A32-8B35-A35846F22A6FQ38261531-10BCAA5C-71B6-4230-8B65-4F58058825A8Q38630648-3D17C93B-BC14-467E-8838-B9E50DAAAC68Q40890601-E3B93340-349F-4208-89B1-A5C39F80F9E7Q41171757-6A3CD096-5DF2-4888-AC01-C9A3D6669E3CQ44633660-CCEED91F-AF3F-463F-9B2E-3CF85FCD8B89Q45021226-CC553B9D-6FD6-4AA4-A08F-F64AE1495412Q47123513-816ECDD0-56CF-4738-A2A4-4254A14B9311Q47201235-76781D5A-33DE-4158-A2AF-EAA9B1EFCB1CQ47253051-D5734E64-C0A0-4041-8E00-412CC127DF70Q47303718-B2406EAF-ECAD-4101-9257-2D90CD3B65A7Q47885172-DAB8FA26-3ECB-44D5-92B0-770F2762BE6BQ48007236-DCA12AF3-B5BD-41CD-B26E-05D03389C615Q48039892-B1CA705E-5EB9-4084-90BF-92B51E37AC20Q48082759-E6839E89-8114-4ACF-BC60-A5525B073294Q48085548-C94C5DEE-288A-4451-A6D6-935CD521DCCCQ48149560-6D0F221F-E30D-49B7-8846-898654D4A200Q48414932-4C4100E0-9416-4FB5-82A1-8630B54A096EQ50851397-9BF32096-7E8B-4B33-B998-93BEF4320241Q51802248-35E3B3B8-ED0E-468B-BD9F-2E8340A7953AQ58698517-B7AD311A-C27D-47A5-992B-0CB765926E5C
P2860
Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Construction of an efficient e ...... enia gravis: the MG composite.
@ast
Construction of an efficient e ...... enia gravis: the MG composite.
@en
type
label
Construction of an efficient e ...... enia gravis: the MG composite.
@ast
Construction of an efficient e ...... enia gravis: the MG composite.
@en
altLabel
Construction of an efficient e ...... henia gravis: the MG composite
@en
prefLabel
Construction of an efficient e ...... enia gravis: the MG composite.
@ast
Construction of an efficient e ...... enia gravis: the MG composite.
@en
P2093
P356
P1433
P1476
Construction of an efficient e ...... enia gravis: the MG composite.
@en
P2093
Donald B Sanders
Gary R Cutter
Mark R Conaway
Muscle Study Group
P2860
P304
P356
10.1002/MUS.21185
P407
P577
2008-12-01T00:00:00Z